Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
National Institute on Drug Abuse, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
RespireRx Pharma Enters into Research Agreement with National Institute of Drug Abuse 11
Addex Therapeutics Enters into Partnership with National Institute on Drug Abuse 12
National Institute on Drug Abuse and AstraZeneca Enter into Partnership 13
Lightlake Therapeutics Enters Into Co-Development Agreement With National Institute On Drug Abuse 14
Lightlake Therapeutics Expands Co-Developmenet Agreement With National Institute On Drug Abuse 15
Licensing Agreements 16
Opiant Pharma Enters into Licensing Agreement with Walter Reed Army Institute of Research and National Institute on Drug Abuse 16
EncepHeal Therapeutics Enters into Licensing Agreement with National Institute on Drug Abuse 17
National Institute on Drug Abuse – Key Competitors 18
National Institute on Drug Abuse – Key Employees 19
National Institute on Drug Abuse – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Government and Public Interest 21
Oct 31, 2018: Columbia University receives National Institute on Drug Abuse (NIDA) research grant to study impact of medical cannabis on opioid use in collaboration with Columbia Care 21
Sep 24, 2018: MEBIAS Discovery receives grant from NIDA 22
Sep 17, 2018: Ensysce Biosciences receives multi-year NIDA grant to study and deliver opioid overdose protection 23
Jul 24, 2018: NIH expands program that conducts large-scale clinical trials in real-world settings 24
Jul 09, 2018: Study casts doubt on effectiveness of e-cigs for smoking cessation 25
Jun 28, 2018: New clinician screening tool available for substance use 26
Jun 22, 2018: Analysis of insurance coverage for back pain shows missed opportunities to prescribe non-opioid medications 27
Jun 22, 2018: UCLA receives $9.5 million grant to study link between substance use and HIV transmission 28
Jun 19, 2018: Methadone and buprenorphine reduce risk of death after opioid overdose 29
Mar 28, 2018: Study changes long-held concepts of cell decoding 30
Nov 01, 2017: Understanding Addiction in the Adolescent Mind 31
Sep 27, 2017: NIH announces centers for myalgic encephalomyelitis/chronic fatigue syndrome research 33
Sep 27, 2017: Camino Pharma Co-founder Receives $10.8 Million Grant for Development of Potential Drug for Cocaine and Nicotine Addiction 35
Sep 26, 2017: UAMS Neuroscientist Receives Grant to Study Resilience of Brain to Mental Illness 36
Sep 15, 2017: Immune System Linked to Alcohol Drinking Behaviour 37
Sep 05, 2017: Treatment for Opioid or Alcohol Abuse Can Be Successful in Primary Care Settings 39
Aug 01, 2017: Collins, King Announce $185,413 in Funding to the University of New England to Support Addiction Research 41
Apr 19, 2017: EncepHeal Therapeutics Receives $300,000 Grant. 42
Apr 19, 2017: EncepHeal Therapeutics Receives $150,000 Notice of Award from the North Carolina Biotechnology Center. 43
Apr 05, 2017: NIDA announces recipients of 2017 Avant-Garde Awards for HIV/AIDS research 44
Jan 30, 2017: New TSRI Study Shows Early Brain Changes in Fragile X Syndrome 46
Product News 47
Dec 20, 2017: Seven Emmes Employees Recognized in Lancet Study Comparing Two Opioid Treatments 47
Other Significant Developments 48
Aug 31, 2018: Novel intervention halves rate of death among people living with HIV who inject drugs 48
Aug 22, 2018: US government orders 3.6 million SPECTRUM research cigarettes from 22nd Century 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Key Facts 2
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
National Institute on Drug Abuse, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
National Institute on Drug Abuse, Deals By Therapy Area, 2012 to YTD 2018 9
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
RespireRx Pharma Enters into Research Agreement with National Institute of Drug Abuse 11
Addex Therapeutics Enters into Partnership with National Institute on Drug Abuse 12
National Institute on Drug Abuse and AstraZeneca Enter into Partnership 13
Lightlake Therapeutics Enters Into Co-Development Agreement With National Institute On Drug Abuse 14
Lightlake Therapeutics Expands Co-Developmenet Agreement With National Institute On Drug Abuse 15
Opiant Pharma Enters into Licensing Agreement with Walter Reed Army Institute of Research and National Institute on Drug Abuse 16
EncepHeal Therapeutics Enters into Licensing Agreement with National Institute on Drug Abuse 17
National Institute on Drug Abuse, Key Competitors 18
National Institute on Drug Abuse, Key Employees 19
List of Figures
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9